Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$8.69
-0.6%
$9.86
$5.83
$13.50
$354.90M0.6589,653 shs719,749 shs
AtriCure, Inc. stock logo
ATRC
AtriCure
$29.26
-1.6%
$32.47
$20.20
$43.11
$1.47B1.56578,508 shs294,855 shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$415.29
-2.3%
$410.38
$385.46
$627.88
$160.43B0.772.02 million shs2.65 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$210.91
-4.8%
$217.98
$187.43
$352.33
$15.92B1.09740,960 shs1.47 million shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-0.57%-6.76%-15.05%-8.72%+17.43%
AtriCure, Inc. stock logo
ATRC
AtriCure
-1.65%-4.75%-7.43%-8.59%+16.71%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
-2.35%-4.54%+5.80%-2.54%-25.18%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-4.91%-7.06%-3.34%+4.52%-35.51%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
4.0672 of 5 stars
3.52.00.04.22.51.70.6
AtriCure, Inc. stock logo
ATRC
AtriCure
3.1039 of 5 stars
3.54.00.00.01.92.50.6
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
4.9933 of 5 stars
4.45.02.54.13.42.52.5
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.8039 of 5 stars
3.45.01.73.22.41.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
3.00
Buy$19.00118.64% Upside
AtriCure, Inc. stock logo
ATRC
AtriCure
3.00
Buy$50.6773.16% Upside
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.80
Moderate Buy$599.3044.31% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.89
Moderate Buy$320.0051.72% Upside

Current Analyst Ratings Breakdown

Latest ANGO, TMO, WST, and ATRC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/18/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$573.00 ➝ $553.00
7/16/2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$24.00
7/16/2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00
7/16/2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$15.00 ➝ $17.00
7/11/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Sector Outperform$590.00
7/8/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$500.00 ➝ $460.00
7/8/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$500.00 ➝ $480.00
6/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$475.00 ➝ $450.00
6/24/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$245.00
5/22/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/30/2025
AtriCure, Inc. stock logo
ATRC
AtriCure
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$60.00 ➝ $60.00
(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$292.50M1.21$0.48 per share17.94$4.51 per share1.93
AtriCure, Inc. stock logo
ATRC
AtriCure
$465.31M3.11N/AN/A$9.46 per share3.09
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$42.88B3.66$29.35 per share14.15$129.54 per share3.21
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.89B5.24$8.58 per share24.59$37.04 per share5.69
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$184.35M-$0.83N/AN/AN/A-11.62%-3.20%-2.09%10/2/2025 (Estimated)
AtriCure, Inc. stock logo
ATRC
AtriCure
-$44.70M-$0.81N/AN/AN/A-7.95%-5.68%-4.34%7/29/2025 (Estimated)
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.34B$17.0524.3616.252.2615.19%17.15%8.47%7/23/2025 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$492.70M$6.3733.1126.835.4516.13%18.23%13.51%7/24/2025 (Estimated)

Latest ANGO, TMO, WST, and ATRC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/29/2025Q2 2025
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.15N/AN/AN/A$130.17 millionN/A
7/24/2025Q2 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.51N/AN/AN/A$725.11 millionN/A
7/23/2025Q2 2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.22N/AN/AN/A$10.68 billionN/A
7/15/2025Q4 2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$0.12-$0.03+$0.09-$0.15$74.26 million$80.16 million
4/29/2025Q1 2025
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.25-$0.14+$0.11-$0.14$122.92 million$123.62 million
4/24/2025Q1 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.22$1.45+$0.23$1.23$685.24 million$698.00 million
4/23/2025Q1 2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.10$5.15+$0.05$3.98$10.23 billion$10.36 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/AN/AN/AN/AN/A
AtriCure, Inc. stock logo
ATRC
AtriCure
N/AN/AN/AN/AN/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.720.41%N/A10.09%8 Years
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.840.40%N/A13.19%N/A

Latest ANGO, TMO, WST, and ATRC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/10/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.430.4%9/15/20259/15/202510/15/2025
4/24/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.210.39%7/30/20257/30/20258/6/2025
5/21/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.430.43%6/13/20256/13/20257/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/A
2.21
1.40
AtriCure, Inc. stock logo
ATRC
AtriCure
0.16
4.11
2.88
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.64
1.77
1.38
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.08
2.77
2.03

Institutional Ownership

CompanyInstitutional Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
89.43%
AtriCure, Inc. stock logo
ATRC
AtriCure
99.11%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
89.23%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
5.40%
AtriCure, Inc. stock logo
ATRC
AtriCure
3.50%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.33%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.53%
CompanyEmployeesShares OutstandingFree FloatOptionable
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
76040.61 million38.41 millionOptionable
AtriCure, Inc. stock logo
ATRC
AtriCure
1,30049.51 million47.77 millionOptionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
125,000377.49 million376.25 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60071.85 million71.46 millionOptionable

Recent News About These Companies

West to Host Second-Quarter 2025 Conference Call

New MarketBeat Followers Over Time

Media Sentiment Over Time

AngioDynamics stock logo

AngioDynamics NASDAQ:ANGO

$8.69 -0.05 (-0.57%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$8.69 0.00 (0.00%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

AtriCure stock logo

AtriCure NASDAQ:ATRC

$29.26 -0.49 (-1.65%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$29.26 +0.00 (+0.02%)
As of 07/18/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Thermo Fisher Scientific stock logo

Thermo Fisher Scientific NYSE:TMO

$415.29 -9.69 (-2.28%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$417.26 +1.96 (+0.47%)
As of 07/18/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$210.91 -10.68 (-4.82%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$210.45 -0.46 (-0.22%)
As of 07/18/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.